To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases.

Background: Over the past 30 years, the healthcare industry has increasingly turned its attention to rare diseases. Regulators have emphasized the need for clinical research in this area to be patient-centered. However, there is a lack of evidence concerning whether this need is actually met.